Citadel Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $197M | Sell |
3,253,900
-694,300
| -18% | -$40.5M | 0.03% | 456 |
|
|
2025
Q4 | $213M | Buy |
3,948,200
+43,800
| +1% | +$2.11M | 0.03% | 459 |
|
|
2025
Q3 | $176M | Buy |
3,904,400
+374,900
| +11% | +$17.5M | 0.03% | 537 |
|
|
2025
Q2 | $163M | Sell |
3,529,500
-1,202,900
| -25% | -$59M | 0.03% | 490 |
|
|
2025
Q1 | $289M | Sell |
4,732,400
-95,000
| -2% | -$5.54M | 0.05% | 260 |
|
|
2024
Q4 | $273M | Sell |
4,827,400
-2,312,500
| -32% | -$129M | 0.05% | 289 |
|
|
2024
Q3 | $369M | Buy |
7,139,900
+1,420,100
| +25% | +$66.6M | 0.07% | 196 |
|
|
2024
Q2 | $238M | Buy |
5,719,800
+1,821,500
| +47% | +$81.5M | 0.05% | 290 |
|
|
2024
Q1 | $211M | Buy |
3,898,300
+1,083,400
| +38% | +$55.2M | 0.04% | 353 |
|
|
2023
Q4 | $144M | Buy |
2,814,900
+401,600
| +17% | +$21.1M | 0.03% | 493 |
|
|
2023
Q3 | $140M | Buy |
2,413,300
+909,700
| +61% | +$55.7M | 0.03% | 466 |
|
|
2023
Q2 | $96.2M | Sell |
1,503,600
-226,800
| -13% | -$15.2M | 0.02% | 633 |
|
|
2023
Q1 | $120M | Sell |
1,730,400
-1,835,900
| -51% | -$129M | 0.03% | 540 |
|
|
2022
Q4 | $257M | Buy |
3,566,300
+560,000
| +19% | +$42.2M | 0.06% | 252 |
|
|
2022
Q3 | $214M | Sell |
3,006,300
-955,700
| -24% | -$69.3M | 0.05% | 287 |
|
|
2022
Q2 | $305M | Sell |
3,962,000
-72,200
| -2% | -$5.5M | 0.08% | 168 |
|
|
2022
Q1 | $295M | Buy |
4,034,200
+2,772,100
| +220% | +$186M | 0.06% | 219 |
|
|
2021
Q4 | $78.7M | Sell |
1,262,100
-543,800
| -30% | -$31.9M | 0.02% | 828 |
|
|
2021
Q3 | $107M | Buy |
1,805,900
+931,300
| +106% | +$61.3M | 0.02% | 621 |
|
|
2021
Q2 | $58.4M | Sell |
874,600
-73,800
| -8% | -$4.81M | 0.01% | 1009 |
|
|
2021
Q1 | $59.9M | Sell |
948,400
-624,300
| -40% | -$38.8M | 0.01% | 904 |
|
|
2020
Q4 | $97.6M | Sell |
1,572,700
-1,105,400
| -41% | -$68M | 0.03% | 571 |
|
|
2020
Q3 | $161M | Buy |
2,678,100
+1,038,100
| +63% | +$62.5M | 0.05% | 262 |
|
|
2020
Q2 | $96.4M | Sell |
1,640,000
-29,900
| -2% | -$1.79M | 0.03% | 424 |
|
|
2020
Q1 | $93.1M | Buy |
1,669,900
+96,600
| +6% | +$5.9M | 0.04% | 360 |
|
|
2019
Q4 | $101M | Buy |
1,573,300
+650,300
| +70% | +$37.2M | 0.04% | 385 |
|
|
2019
Q3 | $46.8M | Sell |
923,000
-86,400
| -9% | -$4.06M | 0.02% | 795 |
|
|
2019
Q2 | $45.8M | Sell |
1,009,400
-905,800
| -47% | -$42.2M | 0.02% | 779 |
|
|
2019
Q1 | $91.4M | Sell |
1,915,200
-732,300
| -28% | -$36.5M | 0.05% | 398 |
|
|
2018
Q4 | $138M | Sell |
2,647,500
-254,100
| -9% | -$13.7M | 0.08% | 222 |
|
|
2018
Q3 | $180M | Sell |
2,901,600
-543,500
| -16% | -$32.3M | 0.08% | 201 |
|
|
2018
Q2 | $191M | Buy |
3,445,100
+875,200
| +34% | +$47.3M | 0.09% | 164 |
|
|
2018
Q1 | $163M | Sell |
2,569,900
-760,200
| -23% | -$48.9M | 0.09% | 171 |
|
|
2017
Q4 | $204M | Buy |
3,330,100
+745,900
| +29% | +$46.7M | 0.12% | 134 |
|
|
2017
Q3 | $165M | Buy |
2,584,200
+578,200
| +29% | +$33.8M | 0.13% | 121 |
|
|
2017
Q2 | $112M | Buy |
2,006,000
+879,100
| +78% | +$47.8M | 0.09% | 196 |
|
|
2017
Q1 | $61.3M | Sell |
1,126,900
-36,800
| -3% | -$2.02M | 0.06% | 355 |
|
|
2016
Q4 | $68M | Sell |
1,163,700
-1,057,000
| -48% | -$57.8M | 0.07% | 276 |
|
|
2016
Q3 | $120M | Buy |
2,220,700
+1,951,400
| +725% | +$125M | 0.12% | 122 |
|
|
2016
Q2 | $19.8M | Sell |
269,300
-150,700
| -36% | -$10.6M | 0.02% | 789 |
|
|
2016
Q1 | $26.8M | Buy |
420,000
+257,600
| +159% | +$16.2M | 0.03% | 580 |
|
|
2015
Q4 | $11.2M | Sell |
162,400
-68,100
| -30% | -$4.5M | 0.01% | 1187 |
|
|
2015
Q3 | $13.6M | Buy |
230,500
+20,800
| +10% | +$1.32M | 0.01% | 1136 |
|
|
2015
Q2 | $14M | Buy |
209,700
+11,200
| +6% | +$738K | 0.01% | 1248 |
|
|
2015
Q1 | $12.8M | Sell |
198,500
-82,500
| -29% | -$5.16M | 0.01% | 1259 |
|
|
2014
Q4 | $16.6M | Buy |
281,000
+34,100
| +14% | +$1.92M | 0.02% | 1068 |
|
|
2014
Q3 | $12.6M | Sell |
246,900
-105,600
| -30% | -$5.27M | 0.01% | 1209 |
|
|
2014
Q2 | $17.1M | Buy |
352,500
+71,300
| +25% | +$3.51M | 0.02% | 906 |
|
|
2014
Q1 | $14.6M | Sell |
281,200
-267,200
| -49% | -$14.2M | 0.02% | 1037 |
|
|
2013
Q4 | $29.1M | Sell |
548,400
-46,900
| -8% | -$2.39M | 0.04% | 605 |
|
|
2013
Q3 | $27.6M | Buy |
595,300
+74,100
| +14% | +$3.25M | 0.04% | 571 |
|
|
2013
Q2 | $23.3M | Buy |
+521,200
| New | +$22.6M | 0.04% | 580 |
|
Other funds holding BMY
VCM
VPM
Citadel Advisors's BMY Position: Q1 2026 in Review
Citadel Advisors increased its Bristol-Myers Squibb (BMY) stake by 46% in Q1 2026, buying an estimated $27.5M and bringing the position to 1,494,234 shares worth $90.6M. The position accounts for 0.01% of the portfolio, ranked #884.
Citadel Advisors first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $456M in Q2 2024. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Citadel Advisors held 1,494,234 shares of Bristol-Myers Squibb worth $90.6M as of Q1 2026.
- Citadel Advisors bought 471,773 Bristol-Myers Squibb shares in Q1 2026, an estimated $27.5M.
- Bristol-Myers Squibb made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #884 holding.
- Citadel Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Citadel Advisors's Bristol-Myers Squibb position peaked at $456M in Q2 2024.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.